These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4881892)

  • 1. Pituitary-adrenal suppression and Cushing's syndrome after intermittent dexamethasone therapy.
    Rabhan NB
    Ann Intern Med; 1968 Dec; 69(6):1141-8. PubMed ID: 4881892
    [No Abstract]   [Full Text] [Related]  

  • 2. Cushing's syndrome. An evaluation of the clinical usefulness of urinary free cortisol and other urinary steroid measurements in diagnosis.
    Burke CW; Beardwell CG
    Q J Med; 1973 Jan; 42(165):175-204. PubMed ID: 4688791
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical studies on the stimulation and suppression of the pituitary-adrenocortical system. II. Studies on the pituitary-adrenocortical suppression test].
    Sako T
    Nihon Naibunpi Gakkai Zasshi; 1968 Dec; 44(9):1016-24. PubMed ID: 4304528
    [No Abstract]   [Full Text] [Related]  

  • 4. Suppression of ACTH by cortisol in dexamethasone-nonsuppressible Cushing's disease.
    Carey RM
    N Engl J Med; 1980 Jan; 302(5):275-9. PubMed ID: 6243171
    [No Abstract]   [Full Text] [Related]  

  • 5. Cushing's syndrome complicating pregnancy. A case report.
    Wieland RG; Shaffer MB; Glove RP
    Obstet Gynecol; 1971 Dec; 38(6):841-3. PubMed ID: 5125430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Autonomous Cushing's syndrome due to a undifferentiated pituitary gland carcinoma].
    Rosner JM; Calandra R; Perazzo D; Banke L; Hass J
    Rev Argent Endocrinol Metab; 1966 Dec; 12(4):234-43. PubMed ID: 5999578
    [No Abstract]   [Full Text] [Related]  

  • 7. Reliability and significance of the dexamethasone suppression test in Cushing's disease.
    N Engl J Med; 1967 Aug; 277(8):431. PubMed ID: 4378315
    [No Abstract]   [Full Text] [Related]  

  • 8. Cushing's syndrome with suppression of the hypothalamic-pituitary-adrenal axis after intra-articular steroid injections.
    O'Sullivan MM; Rumfeld WR; Jones MK; Williams BD
    Ann Rheum Dis; 1985 Aug; 44(8):561-3. PubMed ID: 4026419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantation of the sella turcica with 90-yttrium in the treatment of Cushing's syndrome of pituitary origin.
    Molinatti GM; Camanni F; Massara F; Messina M
    J Clin Endocrinol Metab; 1967 Jun; 27(6):861-76. PubMed ID: 6026365
    [No Abstract]   [Full Text] [Related]  

  • 10. [Investigation of Cushing's syndrome. The diagnostic value of the dexamethasone suppression test, the metopirone test and the CRF test].
    Johannesen O; Jørgensen H; Frey H; Norman N
    Tidsskr Nor Laegeforen; 1989 Sep; 109(26):2678-82. PubMed ID: 2554527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paradoxical response to dexamethasone-suppression in Cushing's disease with adrenal hyperplasia.
    Winkler G; Huhnstock K; Graef V
    Rass Neurol Veg; 1969; 23(5):187-93. PubMed ID: 4328312
    [No Abstract]   [Full Text] [Related]  

  • 12. Cushing's disease: megadose dexamethasone suppression in a case refractory to medical therapy.
    Warren SE; Westbie DK; Daly R; Bower RH
    South Med J; 1979 Apr; 72(4):412-4. PubMed ID: 219547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cushing's syndrome: diagnostic value of hormone determinations and adrenal gammagraphy. Apropos of 21 patients].
    González Atienza J; Anglada Barceló J; Tresánchez Trías JM
    Med Clin (Barc); 1984 Mar; 82(9):388-91. PubMed ID: 6325835
    [No Abstract]   [Full Text] [Related]  

  • 14. Suppression of activity of the adrenal cortex by dexamethasone in Cushing's syndrome.
    Cassidy CE; Rosenfeld PS; Bokat MA
    J Clin Endocrinol Metab; 1966 Nov; 26(11):1181-4. PubMed ID: 5924281
    [No Abstract]   [Full Text] [Related]  

  • 15. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Yanovski JA; Cutler GB; Chrousos GP; Nieman LK
    JAMA; 1993 May; 269(17):2232-8. PubMed ID: 8386285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical management of adrenocortical tumors with Cushing's syndrome.
    Scott HW; Foster JH; Rhamy RK; Klatte E; Liddle GW
    Ann Surg; 1971 Jun; 173(6):892-905. PubMed ID: 4325382
    [No Abstract]   [Full Text] [Related]  

  • 17. Observations and comments on failure of dexamethasone suppression.
    Linn JE; Bowdoin B; Farmer TA; Meador CK
    N Engl J Med; 1967 Aug; 277(8):403-5. PubMed ID: 4378314
    [No Abstract]   [Full Text] [Related]  

  • 18. Cushing's disease with periodic hormonogenesis: one explanation for paradoxical response to dexamethasone.
    Brown RD; Van Loon GR; Orth DN; Liddle GW
    J Clin Endocrinol Metab; 1973 Mar; 36(3):445-51. PubMed ID: 4346603
    [No Abstract]   [Full Text] [Related]  

  • 19. An overnight high-dose dexamethasone suppression test for rapid differential diagnosis of Cushing's syndrome.
    Tyrrell JB; Findling JW; Aron DC; Fitzgerald PA; Forsham PH
    Ann Intern Med; 1986 Feb; 104(2):180-6. PubMed ID: 3004275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cushing's disease. St. Thomas Hospital.
    J Tenn Med Assoc; 1971 Oct; 64(10):871-6. PubMed ID: 5116731
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.